T Naganuma ¹, Y Takemoto ², T Iwai ², N Kuwabara ², J Uchida ², T Nakatani ², K Kitamura ³, A Masuda ³, K Ohmori ⁴, M Matsuura ⁵, H Nakase ⁵ , Transplant Proc. 2016 Apr;48(3):929-32.

This case series found that GMAA in combination with antiviral drugs may shorten the duration of treatment against CMV infection in renal transplant recipients. Further studies in a larger number of patients are required to confirm these results.

https://pubmed.ncbi.nlm.nih.gov/27234770/